Utilization of neurolysis in management of refractory head and neck cancer-related pain in palliative patients: A retrospective review.

Shehryar Nasir KhawajaSteven John Scrivani

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2020)

Chemical neurolysis can provide significant relief to patients with refractory head and neck cancer-related pain as an adjunctive therapy. However, it was found to be associated with mild risk of manageable adverse effects. Shorter chronicity of pain was found to be associated with successful outcome.

Keyphrases

chronic pain
pain management
neuropathic pain
end stage renal disease
ejection fraction
chronic kidney disease
stem cells
spinal cord
mesenchymal stem cells
patient reported outcomes
patient reported
replacement therapy